Atlas Trials

Pancreatic Cancer With Elevated Serum CA125 Were Compared With Those Who Did Not Receive Neoadjuvant Chemotherapy.

Clinical trial NCT04835064 · UNKNOWN

Trial details

NCT number
NCT04835064
Sponsor
Fudan University
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Pancreatic Adenocarcinoma
Start date
2021-04-01
Primary completion
2024-04-01
Enrollment
600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.